Pathstone Holdings’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.2M | Buy |
110,266
+3,930
| +4% | +$436K | 0.05% | 268 |
|
|
2025
Q1 | $11.9M | Buy |
106,336
+1,611
| +2% | +$180K | 0.05% | 281 |
|
|
2024
Q4 | $9.67M | Buy |
104,725
+3,677
| +4% | +$340K | 0.04% | 326 |
|
|
2024
Q3 | $8.47M | Buy |
101,048
+891
| +0.9% | +$74.7K | 0.04% | 383 |
|
|
2024
Q2 | $6.87M | Sell |
100,157
-13,724
| -12% | -$942K | 0.03% | 425 |
|
|
2024
Q1 | $8.34M | Sell |
113,881
-1,709
| -1% | -$125K | 0.04% | 354 |
|
|
2023
Q4 | $9.4M | Buy |
+115,590
| New | +$9.4M | 0.05% | 266 |
|